News | February 24, 2022
Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
100% efficacy against severe Covid-19 disease and hospitalizations
100% efficacy against severe Covid-19 disease and hospitalizations
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Collaboration in the industry needs to be institutionalised to drive the growth.
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.
US $ 555,000 invested by Wavemaker Partners in pre-seed round
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Subscribe To Our Newsletter & Stay Updated
